François Veron’s Post

Every day, I'm reminded of the incredible power of perseverance and innovation. At Roche, we're proud of our long legacy in advancing understanding in neurology, and of our efforts over many years to bring meaningful change to patients. The journey of drug discovery is never easy. But it was through perseverance - and the occasional accident! - that over several decades, dedicated researchers discovered groundbreaking insights into the role of dopamine in brain function. Working in neurology, I take inspiration from the example of pioneers like Markus Guggenheim, who successfully isolated levodopa from broad beans, Arvid Carlsson, who revealed the critical role of dopamine in controlling movement, and Oleh Hornykiewicz, who made the connection between dopamine and Parkinson’s Disease. Brick by brick, these great scientists laid the foundations for the future of disease management, and their experiences teach us a great deal about resilience.  Through their persistent efforts and the incremental advances they, along with numerous others, achieved over the course of 50 years, they ultimately enabled significant advances in neuroscience. I’m proud that at Roche, we never stop exploring, and we continue to build still further on the legacy of those early pioneers. Although the task is daunting, and advances are painstakingly hard-won, we are not discouraged. Their example serves as inspiration for our work, telling us never to give up; to follow our hunches and keep striving to push the boundaries of science. I am impressed by the incredible perseverance of our team, and excited by the possibilities of the future: the innovations that lie just around the corner. Find out more about our innovation stories at: https://lnkd.in/ej7Ux2Xc #Roche #Innovation #Perseverance #Resilience #Legacy #Neurology

Today kicks off the 9th Neurological Disorders Summit in Barcelona, which will bring together neuroscientists and physicians from across the world to share their research and perspectives. With a focus on #epilepsy, #Parkinsons, #Alzheimers, and other neurological disorders, the Summit will provide an overview of the cutting-edge technologies being used to address therapeutic and theoretical issues in #neuroscience. We look forward to hearing about the new and novel research that will emerge from these collaborations and presentations, as well as the transformative impact they will have on the diagnosis, treatment, and understanding of neurological disorders. See the agenda: https://lnkd.in/e_yEZXe

📊 Progress in Alzheimer's Disease Research: A Journey Through Time 🔍 As we commemorate World Alzheimer's Month, it's important to reflect on the strides made in understanding and combating this challenging disease. Our latest #infographic titled "How has Alzheimer's Disease Research Progressed?" offers a look at some of the pivotal moments and discoveries in AD research. From the first identification of Alzheimer��s Disease to today’s clinical trials, the journey has been marked by dedication, collaboration, and innovation. 📌 Dive deep into the evolution of Alzheimer's research over time. Understand the timeline of each discovery and the progress over the years. 📌 Get updated on the latest clinical trials, the number of agents being tested, and some of their potential targets. The path to a world without Alzheimer's is paved with collective efforts, shared knowledge, and unwavering hope. As we move forward, let's celebrate the progress made and gear up for the challenges ahead. #WorldAlzheimersMonth #Alzheimers #Neuroscience #ElixirgenScientific

Join us in celebrating #HBI20YearsofImpact as we share some highlights from the last 20 years! 🎉 In 2014, Dr. Doug Zochodne, a professor in the Department of Clinical Neurosciences, and his team discovered a key molecule that directly regulates nerve cell growth in the damaged nervous system. This surprising discovery was published in the prestigious journal Nature Communications, with lead authors Kim Christie and Anand Krishnan. “We have discovered that a protein called Retinoblastoma (Rb) is present in adult neurons,” explained Zochodne. “This protein appears to normally act as a brake – preventing nerve growth. What we have shown is that by inactivating Rb, we can release the brake and coax nerves to grow much faster.” Learn more: https://bit.ly/4by8Nl8 ------ For two decades, the Hotchkiss Brain Institute has been at the forefront of brain and mental health research, carving out a legacy of innovation, and profound impact. Through the dedicated pursuit of understanding the brain, breaking new ground in treatments, and driving research into community outcomes, the HBI has established itself as a global leader in neuroscience discovery. #HBI #HBI20 #hotchkissbraininstitute #ucalgarymed #ucalgary #neuroscience #brainresearch #nervegrowth #nerveinjury #nervedamage #nerveinjuryresearch Cumming School of Medicine UCalgary

We are delighted to announce an upcoming panel discussion (May 23) to be presented in collaboration with uMotif: "𝗘𝗻𝗿𝗼𝗹𝗹𝗶𝗻𝗴 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀, 𝗠𝗮𝗶𝗻𝘁𝗮𝗶𝗻𝗶𝗻𝗴 𝗘𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁, 𝗮𝗻𝗱 𝗧𝗿𝗮𝗰𝗸𝗶𝗻𝗴 𝗖𝗼𝗴𝗻𝗶𝘁𝗶𝗼𝗻 𝗶𝗻 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀" will delve into the evolving challenges and strategies in trials involving #cognition — particularly those related to #AlzheimersDisease — and how the #clinician can better support the recruitment process. 👉 𝗔𝘁𝘁𝗲𝗻𝗱 𝘁𝗵𝗲 𝘄𝗲𝗯𝗶𝗻𝗮𝗿: https://lnkd.in/ejFWRd43 Our panelists for the event: 🧠 𝗔𝘂𝗱𝗿𝗲𝘆 𝗚𝗮𝗯𝗲𝗹𝗹𝗲, MD, PhD Professor of Neurology, Cognitive Neurologist and Doctor in Neurosciences, Montpellier Excellence Center of Neurodegenerative Disorders   🧠 Bruce Hellman, Chief Patient Officer and Co-Founder, uMotif   🧠 Murray Gillies, PhD, Vice President for Science and Innovation, MoCA Cognition

My journey into the world of neuroscience research began with a profound fascination for the human brain's intricate mysteries. I felt a deep, personal calling to make a significant impact on the field, and it all started with a simple yet powerful wish: to provide scientists with a microfluidic device that could revolutionize the in vitro cultivation of human brain tissue. But my realization came swiftly - my journey was far from solitary. I found myself becoming an integral part of a vibrant and dedicated community. This community was comprised of scientists, engineers, and healthcare professionals who all shared a common vision. Together, we recognized that the collective brilliance within our community had the potential to reshape the future of neuroscience. Today, we find ourselves at a pivotal moment in the field of brain research, and it is thanks to the new groundbreaking concept of the microfluidic device with high throughput potential developed by Pimbio, the microfluidic PimCell® Tube Dish. This device empowers researchers to create and explore three-dimensional models of the human brain with unparalleled precision. It provides the means to replicate the brain's natural environment and functions, thereby opening new frontiers in the study of diseases such as Alzheimer's and Parkinson's. This innovative microfluidic concept holds the promise of developing new treatments that can significantly enhance the lives of millions. The urgency of our mission is undeniable. Neurological disorders touch the lives of countless individuals, and the solutions we seek are tantalizingly within our reach. With our advanced microfluidic device, we hold the key to making groundbreaking discoveries and propelling the frontiers of neuroscience. The time to take action is now, and together, we can collectively shape the future of brain research and, in doing so, enhance the well-being of humanity. Visit our websites www.pimcell.com for more information. #OrganOnAChip #MicrophysiologicalSystems #Organoid #Spheroid #3D #InVitro #Vascularization #ScienceAndResearch #DrugDevelopment #CancerResearch #TumorModels #brain  #neuroscience  #research #neuromarketing #neurotech #bci #psychology #braincomputerinterface #eeg #linkedinforcreators  #AlzheimersResearch #BrainModel #BrainOnAChip #NeurologicalResearch #Biotechnology #LabOnAChip #Microfluidics #NeurologicalStudies #BrainSimulation #InVitroBrain #NeuroscienceTech #BrainHealth  

Today at European Brain Council and Brain Capital Alliance event on #brainhealth for #society: insights from #braincapital Chairing the Panel on #braincapital and #impactinvesting With fellow panelists Shiva Dustdar Ekkehard Ernst Nathalie Hilmi Dan Mannix Christian Schuetz Harris Eyre MD PhD Euro-Mediterranean Economists Association - EMEA In the face of mounting societal challenges, integrating brain capital into impact investing strategies presents a powerful opportunity. By directing essential financial resources towards enhancing cognitive and emotional well-being and mental health, we can unlock unprecedented potential in human capital and beyond: brain capital. This strategic fusion empowers communities, fosters resilience, and ignites innovation, addressing critical global issues from the ground up. Investing in brain capital is not just a financial decision; it is a commitment to nurturing the very core of societal progress and well-being.

A Utility Patent Published! 🚀📜 "Brain Signals Transformation into Audio for Epilepsy Disease" 🧠🎶 I'm thrilled to announce the publication of our latest patent, "Brain Signals Transformation into Audio for Ellipse Disease"! This innovative technology aims to transform how we understand and treat Ellipse Disease by converting complex brain signals into audio representations. Using this technology, we are able to learn more about Ellipse disease by utilising electroencephalogram (EEG) data, which have historically been employed in epilepsy research. Our method, which categorises seizures according to their severity, source, and length, has the potential to improve diagnosis and even help paralysed people regain speech. I'm incredibly pleased with our committed team, whose perseverance and creativity allowed us to accomplish this. In order to enhance the lives of those impacted by neurological disorders, we are collectively pushing the envelope in medical research and innovation. Let's celebrate this milestone and continue our journey of making impactful contributions to the fields of neuroscience and healthcare! 💼💡 #PatentPublished #Innovation #technology #Neuroscience #Healthcare #EllipseDisease #chandigarhuniversity

🌐 Delve deeper into the field of brain science! The special issue from Ageing and Neurodegenerative Diseases Journal on "Glial Activation in Brain Disease" is now accepting submissions. 🧠 Explore the latest breakthroughs, share your research, and contribute to unraveling the mysteries of glial cells’ involvement in neurological diseases. 📚 We warmly welcome all experts and scholars who are interested in this field to click on the link below to submit articles and participate in the dialogue on the cutting edge of neuroscience! 🔗 https://lnkd.in/gx-BVejw 🌟#Astrocyte #microglia #oligodendrocyte #neurologicaldiseases #GlialActivation #BrainDiseases

Delve into Parkinson’s disease research and care with leading neurologist Professor Bas Bloem at Radboudumc, hailed for integrating clinical practice and groundbreaking research. In this captivating episode, Prof. Bloem shares insights from directing the Centre of Expertise for Parkinson & Movement Disorders, unravelling complexities of the disease. Explore his innovative #ParkinsonNet connecting patients to specialized care, success fostering #patientcentric approaches, and why #multidisciplinary collaboration is vital. You’ll discover Prof. Bloem’s intuitive style balancing research and patient needs, including involving patients in studies. Dive into topics like the role of #pesticides and #airpollution, #genetics vs #environment, and how #exercise benefits brain plasticity. Gain priceless perspectives on managing and researching this complicated disease from one of the top minds shaping Parkinson’s care today. Don’t miss this insider view on innovations in #neurology across specialties! Tune in now to learn from the best. Link to the podcast: https://edu.nl/mn6ay #parkinsonsdisease #research #neuroscience #healthcare